Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
In the United States, 10 million inmates are released every year, and human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) prevalence is several-fold greater in criminal justice populations than in the community. Few effective linkage-to-the-community programs are currently available for prisoners infected with HIV. As a result, combination antiretroviral therapy (cART) is seldom continued after release, and virological and immunological outcomes worsen. Poor HIV treatment outcomes result from a myriad of obstacles that released prisoners face upon reentering the community, including homelessness, lack of medical insurance, relapse to drug and alcohol use, and mental illness. This article will focus on 5 distinct factors that contribute significantly to treatment outcomes for released prisoners infected with HIV and have profound individual and public health implications: (1) adaptation of case management services to facilitate linkage to care; (2) continuity of cART; (3) treatment of substance use disorders; (4) continuity of mental illness treatment; and (5) reducing HIV-associated risk-taking behaviors as part of secondary prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096 · cited 1×
“nofovir among men who have sex with men [102] and a tenofo-”
BackgroundAbdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988 · cited 2×
“Secondary HIV prevention, particularly by maintaining viral suppression [3], is crucial to reducing HIV infection Received 7 March 2011; accepted 7 June 2011.”
BackgroundRelease from prison–a high risk of death for former inmates
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064115 · Cited by 1,684 · cited 1×
“Furthermore, drug overdose is the leading cause of death among released prisoners, and usually occurs within 2 weeks of release [74].”
BackgroundMental Health Problems of Prison and Jail Inmates: (557002006-001)
James, D. J., & Glaze, L. E. (2006) · PsycEXTRA Dataset · doi:10.1037/e557002006-001 · Cited by 1,485
Estimation of HIV Incidence in the United States
Hall, H. I. (2008) · JAMA · doi:10.1001/jama.300.5.520 · Cited by 1,317
Psychiatric Disorders and Repeat Incarcerations: The Revolving Prison Door
Baillargeon, J., Binswanger, I. A., Penn, J. V., Williams, B. A., & Murray, O. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030416 · Cited by 651 · cited 2×
“motivation to adhere to treatment recommendations [62], (2) homelessness that results in decreased adherence as a result of migration and social destabilization [63], (3) unemployment”
BackgroundHIV Prevalence and Associated Risks in Young Men Who Have Sex With Men
Valleroy, L. A. (2000) · JAMA · doi:10.1001/jama.284.2.198 · Cited by 603
Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69162-9 · Cited by 555
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60829-x · Cited by 504 · cited 7×
“Adapted from Altice et al [65] with permission from authors.”
BackgroundMethodInfluentialSelf-citationAlcohol Use and Antiretroviral Adherence: Review and Meta-Analysis
Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b18b6e · Cited by 492 · cited 1×
“adherence to cART [85], resulting in reduced likelihood of achieving HIV virological suppression.”
BackgroundTrust and the Acceptance of and Adherence to Antiretroviral Therapy
Altice, F. L., Mostashari, F., & Friedland, G. H. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200109010-00008 · Cited by 410 · cited 1×
“teristics of the medications or intervention, the interpersonal aspects of the patient-provider relationship, and the general system in which care is provided [66].”
BackgroundSelf-citationAzar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.014 · Cited by 394 · cited 1×
“to poor access to and adherence with antiretroviral therapy [81].”
BackgroundSelf-citationEpidemiological parameters of HI V transmission
Andersen, R. M., & May, R. M. (1988) · Nature · doi:10.1038/333514a0 · Cited by 364
Spaulding, A. C., Seals, R. M., Page, M. J., Brzozowski, A. K., Rhodes, W., & Hammett, T. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007558 · Cited by 360 · cited 1×
“all HIV-infected individuals in the US being within the CJS annually [5].”
BackgroundSelf-citationEffectiveness of a Mental Health Court in Reducing Criminal Recidivism and Violence
McNiel, D. E., & Binder, R. L. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101664 · Cited by 356
Fisher, J. C., Bang, H., & Kapiga, S. H. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318067b4fd · Cited by 350 · cited 1×
“with increased HIV-related risk-taking behaviors [84] and poor”
BackgroundSoriano, V., Puoti, M., Sulkowski, M., Cargnel, A., Benhamou, Y., Peters, M., Mauss, S., Bräu, N., Hatzakis, A., Pol, S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3281084e4d · Cited by 349 · cited 1×
“where injection drug use contributes significantly to HIV transmission [86].”
BackgroundAccessing Antiretroviral Therapy Following Release From Prison
Baillargeon, J. (2009) · JAMA · doi:10.1001/jama.2009.202 · Cited by 289
Revolving Doors: Imprisonment Among the Homeless and Marginally Housed Population
Kushel, M. B., Hahn, J. A., Evans, J. L., Bangsberg, D. R., & Moss, A. R. (2005) · American Journal of Public Health · doi:10.2105/ajph.2005.065094 · Cited by 287 · cited 1×
“motivation to adhere to treatment recommendations [62], (2) homelessness that results in decreased adherence as a result of migration and social destabilization [63], (3) unemployment”
BackgroundSubstance Dependence, Abuse, and Treatment of Jail Inmates, 2002: (514862006-001)
Karberg, J. C., & James, D. J. (2005) · PsycEXTRA Dataset · doi:10.1037/e514862006-001 · Cited by 283
WEXLER, H. K., MELNICK, G., LOWE, L., & PETERS, J. (1999) · The Prison Journal · doi:10.1177/0032885599079003003 · Cited by 280 · cited 1×
“Subjects not randomized; limited durability of effect after 12 months; no description of HIV status of subjects given Wexler et al 1999 [53] 478 Released prisoners; San Diego, CA Nonrandomized clinical trial; behavioral InterventionOne year in-prison therapeutic community program with optional…”
BackgroundMARTIN, S. S., BUTZIN, C. A., SAUM, C. A., & INCIARDI, J. A. (1999) · The Prison Journal · doi:10.1177/0032885599079003002 · Cited by 268 · cited 1×
“Did not evaluate HIVpositive prisoners Martin et al 1999 [49] Drug-involved offenders in standard work-release program (n 5 210) vs in work-release therapeutic community (n 5 279); HIV status not reported; Wilmington, DE Nonrandomized comparative trial of standard work-release vs work-release…”
BackgroundSpringer, S. A., Pesanti, E., Hodges, J., Macura, T., Doros, G., & Altice, F. L. (2004) · Clinical Infectious Diseases · doi:10.1086/421392 · Cited by 260
Self-citationInciardi, J. A., MartIn, S. S., & ButzIn, C. A. (2004) · Crime & Delinquency · doi:10.1177/0011128703258874 · Cited by 249 · cited 1×
“ever, and are therefore labor intensive and costly [76].”
BackgroundHost- and disease-specific factors affecting steatosis in chronic hepatitis C
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Breanndan Moore, S. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80004-4 · Cited by 248
A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease
Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O'Grady, K. E. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.03.002 · Cited by 235 · cited 1×
“Did not evaluate HIV-positive prisoners Kinlock et al 2009 [45] 204 HIV-negative opioid dependent incarcerated men; Baltimore, MD RCT; MAT (methadone) started pre-release vs voucher and referral vs passive referral Prerelease methadone subjects spent more time in treatment and had fewer positive…”
Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318158a461 · Cited by 233 · cited 1×
“Not generalizable to prisoners because methadone not commonly available to prisoners Parsons et al 2007 [38] 143 HIV-positive adults with hazardous drinking; New York, NY RCT; motivational interviewing with CBT skills building (8 sessions) compared with time-matched educational session control At 3…”
BackgroundContingency Management for Treatment of Substance Abuse
Stitzer, M., & Petry, N. (2006) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095219 · Cited by 232
All-Cause and Cause-Specific Mortality Among Men Released From State Prison, 1980–2005
Rosen, D. L., Schoenbach, V. J., & Wohl, D. A. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.121855 · Cited by 224 · cited 1×
“not only continue to experience increased HIV-related mortality [6] but have worsened HIV treatment outcomes, represented by increases in HIV type 1 (HIV-1) RNA levels and decreases in CD41 lymphocyte counts”
BackgroundBuprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.006 · Cited by 223 · cited 1×
“Suboptimal methadone dosing among maintained patients; no HIV treatment outcomes reported Magura et al 2009 [48] Opioid-dependent, HIVnegative jail detainees with ,90 days sentences; New York, NY RCT; MAT (BPN, methadone) BPN preferred over other treatments; BPN vs methadone subjects more likely to…”
BackgroundRich, J. D. (2001) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/78.2.279 · Cited by 199
Broadhead, R. S., Heckathorn, D. D., Altice, F. L., van Hulst, Y., Carbone, M., Friedland, G. H., O’Connor, P. G., & Selwyn, P. A. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00167-8 · Cited by 194 · cited 1×
“Assumed 100% adherence for DAART subjects; does not apply to post-release prisoners Broadhead et al 2002 [30] 14 HIV-positive drug users receiving cART; New Haven, CT Intervention feasibility study; peer-driven intervention using secondary incentives Peer-driven intervention with secondary…”
BackgroundSelf-citationImproved Adherence with Contingency Management
Rosen, M. I., Dieckhaus, K., McMahon, T. J., Valdes, B., Petry, N. M., Cramer, J., & Rounsaville, B. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.0028 · Cited by 175 · cited 1×
“Preliminary data support the use of contingency management for HIV treatment adherence [71], yet randomized controlled trials have”
MethodMargolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003) · Health Psychology · doi:10.1037//0278-6133.22.2.223 · Cited by 173
Sorensen, J. L., Haug, N. A., Delucchi, K. L., Gruber, V., Kletter, E., Batki, S. L., Tulsky, J. P., Barnett, P., & Hall, S. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.09.019 · Cited by 163 · cited 3×
“[41], and material incentives (eg, bus tokens and electronic”
BackgroundMethodInfluentialAltice, F. L., Maru, D. S.-R., Bruce, R. D., Springer, S. A., & Friedland, G. H. (2007) · Clinical Infectious Diseases · doi:10.1086/521166 · Cited by 156 · cited 1×
“Altice et al 2007 [26–28] 141 HIV-positive active drug users; New Haven, CT RCT; DAART provided once-daily, 5 days per week for 6 months.”
BackgroundSelf-citationNeurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship
Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9684-1 · Cited by 149 · cited 1×
“of their lifestyles, comorbid mental illness, or HIV-associated cognitive impairment [67].”
BackgroundSelf-citationPetersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E., & Bangsberg, D. R. (2007) · Clinical Infectious Diseases · doi:10.1086/521250 · Cited by 141 · cited 1×
“Petersen et al 2007[39] 245 HIV-positive marginally housed adults receiving ART; San Francisco, CA Longitudinal cohort with 5 years of observation;pillboxes were compared with non-pillboxes Pillbox use improved ART adherence by 4.1%–4.5% and increased likelihood of virological suppression (OR,…”
MethodInfluentialWohl, D. A., Scheyett, A., Golin, C. E., White, B., Matuszewski, J., Bowling, M., Smith, P., Duffin, F., Rosen, D., Kaplan, A., et al. (2011) · AIDS and Behavior · doi:10.1007/s10461-010-9843-4 · Cited by 133 · cited 5×
“Time and labor intensive; only had follow-up data on half of sample; CM did not include linkage to HIV care Wohl et al 2011 [14] 104 HIV-positive released inmates (n 5 89 had post-release assessment and included in final analysis); North Carolina Randomized controlled trial; 43 received strengths-based bridging CM; co…”
BackgroundInfluentialRoux, P., Carrieri, P., Villes, V., Dellamonica, P., Poizot‐Martin, I., Ravaux, I., & Spire, B. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02323.x · Cited by 129 · cited 1×
“Effects of program on recidivism and relapse to drugs/alcohol not sustainable long-term Roux et al 2008 [50] 276 HIV-positive opioid dependent subjects; France Longitudinal communitybased study; MAT (BPN, Methadone) Subjects more likely to maintain nondetectable viral load if continuously receiving…”
Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2006) · Clinical Infectious Diseases · doi:10.1086/503905 · Cited by 128 · cited 1×
“High drop-out rate; noncorrectional setting Lucas et al 2006 [35] 82 HIV-positive subjects receiving DAART in methadone clinic; 809 HIV-positive subjects in same methadone clinic but receiving ART as SAT; Baltimore, MD Case-control study; DAART vs SAT DAART subjects significantly more likely vs…”
MethodLucas, G. M., Chaudhry, A. A., Hsu, J., Woodson, T., Lau, B. M., Olsen, Y. K., Keruly, J. C., Fiellin, D. A., Finkelstein, R., Barditch‐Crovo, P., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00003 · Cited by 123 · cited 8×
“substance use disorders Altice et al 2011 [42] 295 HIV-positive opioid dependent subjects receiving BPN in integrated HIV treatment settings; multisite study Observational study; MAT (BPN) BPN treatment was associated with increased access to cART; longer retention on BPN associated with higher rates of viral suppress…”
BackgroundInfluentialSpringer, S. A., Chen, S., & Altice, F. L. (2010) · Journal of Urban Health · doi:10.1007/s11524-010-9438-4 · Cited by 121 · cited 2×
“prisoners in sustaining HIV treatment outcomes [46].”
Self-citationReintegrating women leaving jail into urban communities: a description of a model program
Richie, B. E., Freudenberg, N., & Page, J. (2001) · Journal of Heredity · doi:10.1093/jurban/78.2.290 · Cited by 119 · cited 6×
“Not used to stabilize HIV treatment outcomes; suboptimal dosing of methadone given (30 mg) Wexler et al 1992 [52] 682 Prisoners in therapeutic community; 950 prisoners in nontherapeutic community drug treatment; 197 prisoners not receiving treatment; New York Descriptive study (quasi-experimental) comparing in-prison…”
BackgroundInfluentialHart, J. E., Jeon, C. Y., Ivers, L. C., Behforouz, H. L., Caldas, A., Drobac, P. C., & Shin, S. S. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181d9a330 · Cited by 117
Kushel, M. B., Colfax, G., Ragland, K., Heineman, A., Palacio, H., & Bangsberg, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/505212 · Cited by 115 · cited 1×
“Limited generalizability Kushel et al 2006 [24] 280 HIV-positive homeless and marginally housed adults; San Francisco, CA Prospective observational cohort study of effect of any case management services Moderate CM (vs no or rare CM) associated with improved ART adherence and CD41 count.”
BackgroundBae, J., Guyer, W., Grimm, K., & Altice, F. L. (2011) · AIDS · doi:10.1097/qad.0b013e328340feb0 · Cited by 114 · cited 1×
“associated opportunistic infections [11].”
Self-citationFord, N. P., Nachega, J. B., Engel, M. E., & Mills, E. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61671-8 · Cited by 114 · cited 1×
“not beneficial overall [72]; however, individuals who were at”
BackgroundAvants, S. K., Margolin, A., Usubiaga, M. H., & Doebrick, C. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00159-4 · Cited by 114 · cited 1×
“Continued Study Study population and location Study design and intervention Primary findings Major limitations Avants et al 2004 [57] 220 HIV-positive drug users in a methadone program; Connecticut RCT; 12-session harm reduction intervention based on InformationMotivation-Behavioral Skills compared…”
MethodThe Effectiveness of In-Jail Methadone Maintenance
Magura, S., Rosenblum, A., Lewis, C., & Joseph, H. (1993) · Journal of Drug Issues · doi:10.1177/002204269302300106 · Cited by 108 · cited 1×
“…adherence, and viral suppression outcomes did not differ between arms Not generalizable; non-CJS population; baseline characteristics not equal Magura et al 1993[32] 308 Opioid-dependent jail inmates in methadone unit; 138 incarcerated controls; HIV status not reported (Project KEEP); New…”
BackgroundA public health model to connect correctional health care with communities.
Conklin, T. J., Lincoln, T., & Flanigan, T. (1998) · PubMed · Cited by 106
Filling the Gap: The Importance of Medicaid Continuity for Former Inmates
Wakeman, S. E., McKinney, M. E., & Rich, J. D. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0977-x · Cited by 99 · cited 1×
“mote continuity of care by policy makers [61].”
BackgroundSerfaty, L., Poujol‐Robert, A., Carbonell, N., Chazouillères, O., Poupon, R. E., & Poupon, R. Y. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04149-7 · Cited by 97
Linkage to Treatment and Supportive Services Among HIV-Positive Ex-Offenders in Project Bridge
Zaller, N. D., Holmes, L., Dyl, A. C., Mitty, J. A., Beckwith, C. G., Flanigan, T., & Rich, J. D. (2008) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.0.0030 · Cited by 92 · cited 2×
“costly intensive CM interventions [19], a randomized controlled”
BackgroundThe Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates.
Tomasino, V., Swanson, A. J., Nolan, J., & Shuman, H. I. (2001) · PubMed · Cited by 91
Altice, F. L., Springer, S. A., Buitrago, M., Hunt, D. P. J., & Friedland, G. H. (2003) · Journal of Heredity · doi:10.1093/jurban/jtg053 · Cited by 85
Self-citationLucas, G. M., Weidle, P. J., Hader, S., & Moore, R. D. (2004) · Clinical Infectious Diseases · doi:10.1086/421405 · Cited by 83 · cited 1×
“Lucas et al 2004 [34] 128 HIV-positive, opioiddependent drug users enrolled in methadone program; Baltimore, MD Nonrandomized comparative trial of DAART; adherence counseling and a matched control group Only 48% of subjects who received adherence support (peer support plus education) achieved…”
MethodMethadone maintenance reduces injecting in prison
Dolan, K. A., Hall, W., & WODAK, A. D. (1996) · BMJ · doi:10.1136/bmj.312.7039.1162b · Cited by 82 · cited 1×
“Continued Study Study population and location Study design and intervention Primary findings Major limitations Dolan et al 1996 [43] 185 Released prisoners, injecting drug users, unknown HIV serostatus; New South Wales, Australia Cross-sectional; MAT (Methadone) Subjects reported significantly less…”
BackgroundMacalino, G. E., Hogan, J. W., Mitty, J. A., Bazerman, L. B., DeLong, A. K., Loewenthal, H., Caliendo, A. M., & Flanigan, T. P. (2007) · AIDS · doi:10.1097/qad.0b013e32811ebf68 · Cited by 82 · cited 1×
“Noncorrectional setting; not generalizable as methadone rarely available to released prisoners Macalino et al 2007 [36] 87 HIV-positive substance users in community; Providence, RI RCT; modified DAART administered oncedaily and 5 days per week for 3 months DAART group more likely to achieve viral…”
BackgroundDirectly Observed Therapy to Treat HIV Infection in Prisoners
Fontanarosa, P., Babudieri, S., Aceti, A., D'Offizi, G. P., Carbonara, S., & Starnini, G. (2000) · JAMA · doi:10.1001/jama.284.2.179 · Cited by 79 · cited 1×
“Noncorrectional population Babudieri et al 2000 [29] 84 HIV-positive injection drug users in Italian prisons (9 prisons with DAART, 9 prisons with SAT); Italy Case-control study; DAART provided daily for all doses DAART subjects (vs SAT subjects) more likely to achieve nondetectable viral load (62%…”
BackgroundSirotich, F. (2009) · PubMed · Cited by 79
Strategies to enhance linkages between care for HIV/AIDS in jail and community settings
Draine, J., Ahuja, D., Altice, F. L., Arriola, K. J., Avery, A., Beckwith, C. G., Booker, C. A., Ferguson, A., Figueroa, H., Lincoln, T., et al. (2011) · AIDS Care · doi:10.1080/09540121.2010.507738 · Cited by 75 · cited 1×
“linking HIV-infected jail detainees to community care will have clinical outcomes and is currently underway [60].”
BackgroundSelf-citationFacilitators and Barriers to Continuing Healthcare After Jail: A Community-integrated Program
Lincoln, T., Kennedy, S., Tuthill, R., Roberts, C., Conklin, T. J., & Hammett, T. M. (2006) · Journal of Ambulatory Care Management · doi:10.1097/00004479-200601000-00002 · Cited by 75 · cited 3×
“Characteristics of Jail- and Prison-Release Programs State Variable California [12] Connecticut [13] North Carolina [14] New Jersey [15] New York [16] Massachusetts [17, 18] Rhode Island [19–21] Virginia [22] Prison or jail Jail Prison Prison Jail Prison Jail Prison Prison Worked with prisoner before release Yes Yes Y…”
BackgroundMethodRawlings, M. K., Thompson, M. A., Farthing, C. F., Brown, L. S., Racine, J., Scott, R. C., Crawford, K. H., Goodwin, S. D., Tolson, J. M., Williams, V. C., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200310010-00007 · Cited by 72 · cited 1×
“Noncorrectional setting; limited generalizability Rawlings et al 2003 [40] 195 HIV-positive antiretroviral-naive adults in urban community (including 20% injection drug users) prescribed a triple-nucleoside reversetranscriptase inhibitor regimen; Dallas, TX RCT; 4 modules of the Tools for Health…”
BackgroundOutcome Evaluation of a Prison Therapeutic Community for Substance Abuse Treatment
Wexler, H. K., Franklin, G. P., Lipton, D. S., & Rosenblum, A. (1992) · PsycEXTRA Dataset · doi:10.1037/e496162006-012 · Cited by 67
Smith-Rohrberg, D., Mezger, J., Walton, M. R., Bruce, R. D., & Altice, F. L. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248338.74943.85 · Cited by 64 · cited 1×
“Limited generalizability due to organizational healthcare delivery; small sample of HIVpositive subjects (10% of sample) Smith-Rohrberg et al 2006 [25] 72 HIV-positive adults receiving DAART as part of larger RCT; New Haven, CT Prospective observational study of HIV-positive drug users in community…”
BackgroundSelf-citationFlanigan, T., Zaller, N. D., Beckwith, C. G., Bazerman, L. B., Rana, A., Gardner, A. F., Wohl, D. A., & Altice, F. L. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181fbc94f · Cited by 63 · cited 1×
“ventive services to this high-risk population [99] and have”
BackgroundSelf-citationBuprenorphine-naloxone Treatment for Pre-release Opioid-dependent Inmates in Puerto Rico
Garcia, C. A., Correa, G. C., Viver, A. D. H., Kinlock, T. W., Gordon, M. S., Avila, C. A., Reyes, I. C., & Schwartz, R. P. (2007) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31814b8880 · Cited by 61 · cited 1×
“Garcia et al 2007[44] 45 Male HIV-negative opioiddependent prisoners at minimum-security prison; San Juan, Puerto Rico Interventional feasibility study; MAT (BPN) High levels of BPN acceptability when offered prior to release; retention rate 93% after 4 weeks post-release.”
BackgroundSpringer, S. A., Azar, M. M., & Altice, F. L. (2010) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2010.540280 · Cited by 59 · cited 2×
“with HIV has not been critically evaluated [79].”
BackgroundSelf-citationA Prospective Controlled Trial of Routine Opt-Out HIV Testing in a Men's Jail
Kavasery, R., Maru, D., Sylla, L. N., Smith, D. S., & Altice, F. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008056 · Cited by 56 · cited 1×
“within the first 24 hours after incarceration [96, 97].”
BackgroundSelf-citationRoutine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial
Kavasery, R., Maru, D. S.-R., Cornman-Homonoff, J., Sylla, L. N., Smith, D., & Altice, F. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007648 · Cited by 49 · cited 1×
“within the first 24 hours after incarceration [96, 97].”
BackgroundSelf-citationA Collaborative Effort to Enhance HIV/STI Screening in Five County Jails
Arriola, K. J., Braithwaite, R. L., Kennedy, S., Hammett, T., Tinsley, M., Wood, P., & Arboleda, C. (2001) · Public Health Reports · doi:10.1093/phr/116.6.520 · Cited by 48 · cited 1×
“risk behaviors Arriola et al 2001 [56] HIV-negative inmates in 5 county jails; multisite Descriptive; behavioral interventions Modest success of STI test and treat behavioral intervention for primary HIV prevention.”
BackgroundNational Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) Overview
Wexler, H. K., & Fletcher, B. W. (2007) · The Prison Journal · doi:10.1177/0032885506299036 · Cited by 45 · cited 1×
“SUDs are associated with decreased adherence to cART [75].”
BackgroundImplementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence
Leeman, J., Chang, Y., Lee, E. J., Voils, C. I., Crandell, J., & Sandelowski, M. (2010) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05360.x · Cited by 42
Maru, D., Bruce, R. D., Walton, M. R., Springer, S. A., & Altice, F. L. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181938e7e · Cited by 41
Self-citationSmith-Rohrberg, D., Bruce, R. D., & Altice, F. L. (2004) · Journal of Drug Issues · doi:10.1177/002204260403400210 · Cited by 38 · cited 2×
“opioid dependence [78], has recently been adopted in several”
BackgroundMethodSelf-citationComulada, W. S., Rotheram‐Borus, M. J., Pequegnat, W., Weiss, R. E., Desmond, K. A., Arnold, E. M., Remien, R. H., Morin, S. F., Weinhardt, L. S., Johnson, M. O., et al. (2010) · Psychology of Addictive Behaviors · doi:10.1037/a0018190 · Cited by 37 · cited 1×
“behaviors [90] and reincarceration [62].”
Copenhaver, M., Chowdhury, S. P., & Altice, F. L. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0157 · Cited by 35 · cited 1×
“…group (P 5 .03) Non-CJS involved population; lacks generalizability since methadone rarely provided within prison; time intensive intervention Copenhaver et al 2009 [58] 19 Medical and drug treatment providers, 26 HIV-positive released inmates; Connecticut Cross-sectional survey; designed to…”
BackgroundSelf-citationLevasseur, L., Marzo, J., Ross, N., & Blatier, C. (2002) · PubMed · Cited by 28
Copenhaver, M. M., Lee, I., Margolin, A., Bruce, R. D., & Altice, F. L. (2011) · Substance Abuse · doi:10.1080/08897077.2011.540466 · Cited by 26 · cited 2×
“RCT needed Copenhaver et al 2011 [59] 21 HIV-positive subjects with opioid dependence in community-based non-research setting; New Haven, CT Pilot RCT; 4-session briefly delivered intervention (Holistic Health for HIV positive) Significant intervention effect seen in terms of sexual risk reduction…”
BackgroundSelf-citationStrategies for Primary HIV Prevention That Target Behavioral Change
Safren, S. A., Wingood, G. M., & Altice, F. L. (2007) · Clinical Infectious Diseases · doi:10.1086/522554 · Cited by 21 · cited 1×
“adherence to cART are effective and essential [101].”
BackgroundSelf-citationHIV Risk Behavior Before and After HIV Counseling and Testing in Jail: A Pilot Study
Beckwith, C. G., Liu, T., Bazerman, L. B., DeLong, A. K., Desjardins, S., Poshkus, M., & Flanigan, T. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c997b1 · Cited by 21 · cited 1×
“dressed by using rapid HIV diagnostic tests [95] and testing”
MethodImproving Healthcare for Incarcerated Women
Springer, S. A. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1786 · Cited by 21
Self-citationMaru, D., Kozal, M. J., Bruce, R. D., Springer, S. A., & Altice, F. L. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318158c0bd · Cited by 16 · cited 1×
“prisoners and does not promote genotypic resistance [26].”
BackgroundSelf-citationChow, J. M., Joesoef, M. R., Kent, C. K., Weinstock, H., & Fenton, K. A. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181949359 · Cited by 9
Springer, S. A. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02893.x · Cited by 7 · cited 1×
“for opioid and alcohol dependence [65, 77], is relatively less”
BackgroundSelf-citation
Metadata
- Authors
- Springer, S. A., Spaulding, A. C., Meyer, J. P., & Altice, F. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-15
- Volume
- 53
- Issue
- 5
- Pages
- 469-479
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2081716611
- Cited by
- 192
- References
- 87
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.